-
Je něco špatně v tomto záznamu ?
Antigen targeting to CD11b+ dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+ T cell responses
G. Dadaglio, C. Fayolle, X. Zhang, B. Ryffel, M. Oberkampf, T. Felix, S. Hervas-Stubbs, R. Osicka, P. Sebo, D. Ladant, C. Leclerc,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 1998 do Před 1 rokem
Freely Accessible Science Journals
od 1998-01-01 do Před 1 rokem
Open Access Digital Library
od 1998-01-01
PubMed
25024388
DOI
10.4049/jimmunol.1302974
Knihovny.cz E-zdroje
- MeSH
- adaptorové proteiny vezikulární transportní imunologie MeSH
- adenylátcyklasový toxin imunologie MeSH
- antigeny CD11b imunologie MeSH
- antigeny CD80 biosyntéza MeSH
- antigeny CD86 biosyntéza MeSH
- Bordetella pertussis imunologie MeSH
- buněčná diferenciace imunologie MeSH
- cytotoxické T-lymfocyty imunologie MeSH
- dendritické buňky cytologie imunologie MeSH
- interferon beta imunologie MeSH
- interleukin-1beta biosyntéza MeSH
- interleukin-6 biosyntéza MeSH
- kultivované buňky MeSH
- myši inbrední C57BL MeSH
- myši knockoutované MeSH
- myši MeSH
- receptor interferonu alfa-beta genetika MeSH
- receptory interleukinu-1 imunologie MeSH
- signální transdukce imunologie MeSH
- TNF-alfa biosyntéza MeSH
- toll-like receptor 4 imunologie MeSH
- tyrosin genetika MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Deciphering the mechanisms that allow the induction of strong immune responses is crucial to developing efficient vaccines against infectious diseases and cancer. Based on the discovery that the adenylate cyclase from Bordetella pertussis binds to the CD11b/CD18 integrin, we developed a highly efficient detoxified adenylate cyclase-based vector (CyaA) capable of delivering a large variety of Ags to the APC. This vector allows the induction of protective and therapeutic immunity against viral and tumoral challenges as well as against transplanted tumors in the absence of any added adjuvant. Two therapeutic vaccine candidates against human papilloma viruses and melanoma have been developed recently, based on the CyaA vector, and are currently in clinical trials. We took advantage of one of these highly purified vaccines, produced under good manufacturing practice-like conditions, to decipher the mechanisms by which CyaA induces immune responses. In this study, we demonstrate that CyaA binds both human and mouse CD11b(+) dendritic cells (DCs) and induces their maturation, as shown by the upregulation of costimulatory and MHC molecules and the production of proinflammatory cytokines. Importantly, we show that DCs sense CyaA through the TLR4/Toll/IL-1R domain-containing adapter-inducing IFN-β pathway, independent of the presence of LPS. These findings show that CyaA possesses the intrinsic ability to not only target DCs but also to activate them, leading to the induction of strong immune responses. Overall, this study demonstrates that Ag delivery to CD11b(+) DCs in association with TLR4/Toll/IL-1R domain-containing adapter-inducing IFN-β activation is an efficient strategy to promote strong specific CD8(+) T cell responses.
Centre National de la Recherche Scientifique Unité Mixte de Recherche 3528 Paris F 75015 France
INSERM U1041 Paris F 75015 France
Institut Pasteur Unité de Biochimie des Interactions Macromoléculaires Paris F 75015 France
Institut Pasteur Unité de Régulation Immunitaire et Vaccinologie Paris F 75015 France
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15007991
- 003
- CZ-PrNML
- 005
- 20150325131927.0
- 007
- ta
- 008
- 150306s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.4049/jimmunol.1302974 $2 doi
- 035 __
- $a (PubMed)25024388
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Dadaglio, Gilles $u Institut Pasteur, Unité de Régulation Immunitaire et Vaccinologie, Paris F-75015, France; INSERM, U1041, Paris F-75015, France; gilles.dadaglio@pasteur.fr claude.leclerc@pasteur.fr.
- 245 10
- $a Antigen targeting to CD11b+ dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+ T cell responses / $c G. Dadaglio, C. Fayolle, X. Zhang, B. Ryffel, M. Oberkampf, T. Felix, S. Hervas-Stubbs, R. Osicka, P. Sebo, D. Ladant, C. Leclerc,
- 520 9_
- $a Deciphering the mechanisms that allow the induction of strong immune responses is crucial to developing efficient vaccines against infectious diseases and cancer. Based on the discovery that the adenylate cyclase from Bordetella pertussis binds to the CD11b/CD18 integrin, we developed a highly efficient detoxified adenylate cyclase-based vector (CyaA) capable of delivering a large variety of Ags to the APC. This vector allows the induction of protective and therapeutic immunity against viral and tumoral challenges as well as against transplanted tumors in the absence of any added adjuvant. Two therapeutic vaccine candidates against human papilloma viruses and melanoma have been developed recently, based on the CyaA vector, and are currently in clinical trials. We took advantage of one of these highly purified vaccines, produced under good manufacturing practice-like conditions, to decipher the mechanisms by which CyaA induces immune responses. In this study, we demonstrate that CyaA binds both human and mouse CD11b(+) dendritic cells (DCs) and induces their maturation, as shown by the upregulation of costimulatory and MHC molecules and the production of proinflammatory cytokines. Importantly, we show that DCs sense CyaA through the TLR4/Toll/IL-1R domain-containing adapter-inducing IFN-β pathway, independent of the presence of LPS. These findings show that CyaA possesses the intrinsic ability to not only target DCs but also to activate them, leading to the induction of strong immune responses. Overall, this study demonstrates that Ag delivery to CD11b(+) DCs in association with TLR4/Toll/IL-1R domain-containing adapter-inducing IFN-β activation is an efficient strategy to promote strong specific CD8(+) T cell responses.
- 650 _2
- $a adaptorové proteiny vezikulární transportní $x imunologie $7 D033942
- 650 _2
- $a adenylátcyklasový toxin $x imunologie $7 D037361
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antigeny CD11b $x imunologie $7 D039481
- 650 _2
- $a antigeny CD80 $x biosyntéza $7 D018122
- 650 _2
- $a antigeny CD86 $x biosyntéza $7 D051940
- 650 _2
- $a Bordetella pertussis $x imunologie $7 D001886
- 650 _2
- $a buněčná diferenciace $x imunologie $7 D002454
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a dendritické buňky $x cytologie $x imunologie $7 D003713
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a interferon beta $x imunologie $7 D016899
- 650 _2
- $a interleukin-1beta $x biosyntéza $7 D053583
- 650 _2
- $a interleukin-6 $x biosyntéza $7 D015850
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a myši knockoutované $7 D018345
- 650 _2
- $a receptor interferonu alfa-beta $x genetika $7 D053633
- 650 _2
- $a receptory interleukinu-1 $x imunologie $7 D017472
- 650 _2
- $a signální transdukce $x imunologie $7 D015398
- 650 _2
- $a cytotoxické T-lymfocyty $x imunologie $7 D013602
- 650 _2
- $a toll-like receptor 4 $x imunologie $7 D051197
- 650 _2
- $a TNF-alfa $x biosyntéza $7 D014409
- 650 _2
- $a tyrosin $x genetika $7 D014443
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Fayolle, Catherine $u Institut Pasteur, Unité de Régulation Immunitaire et Vaccinologie, Paris F-75015, France; INSERM, U1041, Paris F-75015, France;
- 700 1_
- $a Zhang, Xiaoming $u Institut Pasteur, Unité de Régulation Immunitaire et Vaccinologie, Paris F-75015, France; INSERM, U1041, Paris F-75015, France;
- 700 1_
- $a Ryffel, Bernard $u Unité Mixte de Recherche 7355, Université d'Orléans-Centre National de la Recherche Scientifique, Laboratoire Immunologie et Neurogénétique Expérimentales et Moléculaires, Orléans 45071, France;
- 700 1_
- $a Oberkampf, Marine $u Institut Pasteur, Unité de Régulation Immunitaire et Vaccinologie, Paris F-75015, France; INSERM, U1041, Paris F-75015, France;
- 700 1_
- $a Felix, Tristan $u Institut Pasteur, Unité de Régulation Immunitaire et Vaccinologie, Paris F-75015, France; INSERM, U1041, Paris F-75015, France;
- 700 1_
- $a Hervas-Stubbs, Sandra $u Division of Gene Therapy and Hepatology, Centre for Applied Medical Research, University of Navarra, Pamplona 31008, Spain;
- 700 1_
- $a Osicka, Radim $u Institute of Microbiology of the Academy of Sciences of the Czech Republic, Verejna Vyzkumna Instituce, Videnska 1083, 142 20 Prague, Czech Republic;
- 700 1_
- $a Sebo, Peter $u Institute of Microbiology of the Academy of Sciences of the Czech Republic, Verejna Vyzkumna Instituce, Videnska 1083, 142 20 Prague, Czech Republic;
- 700 1_
- $a Ladant, Daniel $u Institut Pasteur, Unité de Biochimie des Interactions Macromoléculaires, Paris F-75015, France; and Centre National de la Recherche Scientifique, Unité Mixte de Recherche 3528, Paris F-75015, France.
- 700 1_
- $a Leclerc, Claude $u Institut Pasteur, Unité de Régulation Immunitaire et Vaccinologie, Paris F-75015, France; INSERM, U1041, Paris F-75015, France; gilles.dadaglio@pasteur.fr claude.leclerc@pasteur.fr.
- 773 0_
- $w MED00002741 $t Journal of immunology (Baltimore, Md. 1950) $x 1550-6606 $g Roč. 193, č. 4 (2014), s. 1787-98
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25024388 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150306 $b ABA008
- 991 __
- $a 20150325132216 $b ABA008
- 999 __
- $a ok $b bmc $g 1065264 $s 890791
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 193 $c 4 $d 1787-98 $i 1550-6606 $m The Journal of immunology $n J Immunol $x MED00002741
- LZP __
- $a Pubmed-20150306